GCT Awarded a Rare Genetic Epilepsy Study in Pediatric Patients
A new Neurology Study has been awarded to Global Clinical Trials. It is a trial for children living with a rare epilepsy syndrome characterized by seizures and cognitive delays. The condition is due to a mutation of a gene on the X chromosome.
March 23, 2020
Enrollment Completed by GCT for POAG study
Enrollment goal was reached for the Phase III study in ocular hypertension or primary open angle glaucoma managed by GCT.
POAG is a serious condition in which the measured eye pressure is consistently greater than normal, which leads to optic nerve damage and vision loss.
March 13, 2020
New OB/GYN Study in Ukraine
GCT has been awarded a new randomized, double-blind, three-arm, parallel-group, multicenter superiority study in Ukraine. The goal of the trial is to assess the efficacy and safety of the drug in women suffering from endometriosis.
This is a global study currently run in more than 5 countries. In Ukraine alone GCT will enroll 150 patients at 11 investigational sites.
February 28, 2020
GCT Expands Operations to Kazakhstan
As 2020 begins, GCT expands its operations in Asia, adding the Republic of Kazakhstan to its map.
January 31, 2019
Meet our clients
All trademarks, brand names and logotypes are intellectual property of their respective owners.
Upcoming meetings
-
AAT-AD/PD 2020
Austria Center
Vienna, Austria
2020, April 02—05 -
MAGI 2020 East
Loews Philadelphia
Philadelphia, PA, USA
2020, April 19—22 -
Clinical Trials Innovation Programme
Munich Airport Marriott Hotel
Munich, Germany
2020, April 23—24 -
DIA 2020
Walter E. Washington Convention Center
Washington, DC, USA
2020, June 14-18
